We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
Lexeo Therapeutics, Inc. operates as a clinical stage genetic medicine company that focuses on hereditary and acquired diseases. The company develops LX2006, which is an AAVrh10-based gene therapy candidate for the treatment of Friedreich's ataxia (FA) cardiomyopathy; LX2020, an AAVrh10-based gene t... Lexeo Therapeutics, Inc. operates as a clinical stage genetic medicine company that focuses on hereditary and acquired diseases. The company develops LX2006, which is an AAVrh10-based gene therapy candidate for the treatment of Friedreich's ataxia (FA) cardiomyopathy; LX2020, an AAVrh10-based gene therapy candidate for the treatment of arrhythmogenic cardiomyopathy; LX2021, a gene therapy candidate for the treatment of DSP cardiomyopathy associated; and LX2022, a gene therapy candidate for the treatment of HCM caused by TNNI3 mutations. It also develops LX1001, an AAVrh10-based gene therapy candidate for the treatment of APOE4 homozygous; LX1020, a gene therapy candidate for the treatment of APOE4 homozygous; LX1021 for the treatment of APOE4 homozygotes; and LX1004 for the treatment of CLN2 Batten disease. The company was incorporated in 2017 and is based in New York, New York. Show more
Ask ADVFN Intelligence (AI)
| Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.14 | 5.18518518519 | 2.7 | 2.9896 | 2.51 | 326473 | 2.73719789 | CS |
| 4 | -1.16 | -29 | 4 | 4.7199 | 2.32 | 486107 | 2.97519737 | CS |
| 12 | -3.433 | -54.7266060896 | 6.273 | 7.66 | 2.32 | 320118 | 4.20722553 | CS |
| 26 | -7.33 | -72.0747295969 | 10.17 | 11.72 | 2.32 | 374446 | 6.84430631 | CS |
| 52 | -12.75 | -81.7831943554 | 15.59 | 19.5 | 2.32 | 298257 | 9.57222773 | CS |
| 156 | -6.66 | -70.1052631579 | 9.5 | 22.33 | 2.32 | 250284 | 10.05560149 | CS |
| 260 | -6.66 | -70.1052631579 | 9.5 | 22.33 | 2.32 | 250284 | 10.05560149 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
